- Investing Ideas
- Hong Kong Biotech Stocks
Hong Kong Biotech Stocks
Results
76
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
76 companies
Hansoh Pharmaceutical Group
Market Cap: HK$234.7b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$38.76
7D
-1.5%
1Y
71.5%
Innovent Biologics
Market Cap: HK$153.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$88.50
7D
-3.3%
1Y
85.3%
WuXi Biologics (Cayman)
Market Cap: HK$148.5b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$35.90
7D
2.6%
1Y
80.0%
Akeso
Market Cap: HK$127.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$138.20
7D
-1.6%
1Y
68.1%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$115.0b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$493.00
7D
-2.1%
1Y
63.2%
CSPC Pharmaceutical Group
Market Cap: HK$105.9b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.26
7D
-4.6%
1Y
75.7%
Sino Biopharmaceutical
Market Cap: HK$105.8b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.92
7D
-6.5%
1Y
65.4%
WuXi XDC Cayman
Market Cap: HK$79.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$63.00
7D
3.0%
1Y
87.2%
RemeGen
Market Cap: HK$76.9b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$106.00
7D
-8.0%
1Y
270.6%
3SBio
Market Cap: HK$57.3b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$22.96
7D
-9.5%
1Y
85.2%
Shanghai Henlius Biotech
Market Cap: HK$45.3b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$83.35
7D
8.8%
1Y
191.4%
Shanghai Junshi Biosciences
Market Cap: HK$40.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
1877
HK$24.94
7D
-5.5%
1Y
77.1%
China Resources Pharmaceutical Group
Market Cap: HK$39.8b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$6.34
7D
1.1%
1Y
29.1%
InSilico Medicine Cayman TopCo
Market Cap: HK$35.5b
Operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally.
3696
HK$62.10
7D
8.5%
1Y
n/a
Simcere Pharmaceutical Group
Market Cap: HK$35.5b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$13.74
7D
0.9%
1Y
69.4%
China Medical System Holdings
Market Cap: HK$34.6b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.30
7D
-0.2%
1Y
97.8%
InnoCare Pharma
Market Cap: HK$30.4b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$15.05
7D
-3.0%
1Y
78.7%
Genscript Biotech
Market Cap: HK$28.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.81
7D
3.6%
1Y
22.9%
Duality Biotherapeutics
Market Cap: HK$27.3b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$303.00
7D
-6.4%
1Y
n/a
Grand Pharmaceutical Group
Market Cap: HK$24.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$6.86
7D
-5.0%
1Y
16.1%
Keymed Biosciences
Market Cap: HK$22.1b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$75.00
7D
5.1%
1Y
71.0%
United Laboratories International Holdings
Market Cap: HK$19.9b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$10.09
7D
-4.3%
1Y
-19.3%
Ascentage Pharma Group International
Market Cap: HK$18.1b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$49.14
7D
-5.6%
1Y
32.6%
CStone Pharmaceuticals
Market Cap: HK$14.8b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$10.07
7D
7.7%
1Y
321.3%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$14.5b
Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.
2595
HK$39.26
7D
7.6%
1Y
n/a
Consun Pharmaceutical Group
Market Cap: HK$14.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$17.02
7D
-0.3%
1Y
81.8%
Everest Medicines
Market Cap: HK$13.4b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$38.10
7D
-6.6%
1Y
-21.3%
CanSino Biologics
Market Cap: HK$13.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.74
7D
-0.9%
1Y
10.2%
HBM Holdings
Market Cap: HK$11.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.25
7D
-1.5%
1Y
99.3%
Luye Pharma Group
Market Cap: HK$11.2b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.80
7D
-4.1%
1Y
53.8%
Lepu Biopharma
Market Cap: HK$10.4b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.
2157
HK$5.78
7D
-6.0%
1Y
36.6%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.7b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.39
7D
-0.2%
1Y
19.2%
Shanghai Haohai Biological Technology
Market Cap: HK$9.3b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$22.38
7D
0.6%
1Y
-8.1%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.1b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.81
7D
0.6%
1Y
-6.2%
Abbisko Cayman
Market Cap: HK$8.9b
Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.
2256
HK$13.25
7D
-0.08%
1Y
94.0%
China Shineway Pharmaceutical Group
Market Cap: HK$7.5b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.94
7D
1.8%
1Y
31.0%